Cullinan Oncology
CGEM
CGEM
135 hedge funds and large institutions have $1.1B invested in Cullinan Oncology in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
64% more capital invested
Capital invested by funds: $671M → $1.1B (+$427M)
19% more funds holding
Funds holding: 113 → 135 (+22)
17.76% more ownership
Funds ownership: 91.42% → 109.18% (+18%)
Holders
135
Holding in Top 10
6
Calls
$3.14M
Puts
$286K
Top Buyers
| 1 | +$44.5M | |
| 2 | +$37.4M | |
| 3 | +$29.6M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$27.2M |
| 5 |
VA
VR Adviser
New York
|
+$24.1M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$15.3M | |
| 3 | -$11.9M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$10.7M |
| 5 |
Morgan Stanley
New York
|
-$5.48M |